Internal Medicine, Hematology & Oncology · Vacaville, CA
NPI
1790004943
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1 Quality Dr
Vacaville, CA, 95688
Phone (707) 624-4000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$728K
709 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Chimezie D Ubbaonu prescribed most often to Medicare patients was Prochlorperazine Maleate, with 93 prescriptions and refills. In total Chimezie D Ubbaonu wrote 709 Medicare prescriptions that cost $728K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-22.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Prochlorperazine Maleate Generic | 93 | 93 | 56 | $1,361 |
| Abiraterone Acetate Generic | 69 | 74 | 18 | $11K |
| Dexamethasone Generic | 57 | 60 | 28 | $756 |
| Prednisone Generic | 56 | 110 | 26 | $516 |
| Compro Prochlorperazine | 50 | 50 | 45 | $2,582 |
| Ondansetron Hcl Generic | 46 | 46 | 28 | $366 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 36 | 36 | 15 | $564 |
| Olanzapine Generic | 28 | 28 | 22 | $176 |
| Xtandi Enzalutamide | 27 | 27 | Under 11 | $325K |
| Oxycodone Hcl Generic | 18 | 18 | 11 | $204 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 17 | 17 | 17 | $348 |
| Famotidine Generic | 15 | 15 | 11 | $111 |
| Ondansetron Odt Ondansetron | 14 | 14 | Under 11 | $148 |
| Lorazepam Generic | 14 | 14 | Under 11 | $147 |
| Lenalidomide Generic | 13 | 13 | Under 11 | $156K |
Brand drugs: 55 claims; generic drugs: 654 claims; opioid claims: 62.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Chimezie D Ubbaonu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.